Introduction to p62 and Cellular Homeostasis

The protein SQSTM1/p62 serves as a critical regulator within human cells. It manages autophagic degradation, protein ubiquitination, and the defense against oxidative stress. Notably, p62 exerts its influence through the formation of p62 bodies. These phase-separated structures sequester specific factors to coordinate cellular responses. Scientists have long sought to understand how cells control these dynamics. Recent research now identifies SHKBP1 p62 oligomerization as a central mechanism in this regulatory network.

The Regulatory Mechanism of SHKBP1

Researchers recently discovered that SHKBP1, an adaptor for the Cullin-3 E3 ubiquitin ligase, plays a vital role in managing p62 assembly. Unlike many other adaptors, SHKBP1 functions independently of ubiquitination in this context. It interacts with p62 outside of the established p62 bodies. Consequently, this interaction limits the initial stages of SHKBP1 p62 oligomerization. By restricting how p62 molecules cluster together, SHKBP1 effectively prevents the over-accumulation of large cytoplasmic bodies. This control ensures that the cell maintains a balanced distribution of protein components during times of stress.

SHKBP1 p62 Oligomerization and the Nrf2 Pathway

Furthermore, the regulation of p62 bodies has direct implications for the Keap1-Nrf2 antioxidant pathway. Under normal conditions, p62 bodies sequester Keap1, which usually facilitates the degradation of the transcription factor Nrf2. When p62 bodies form efficiently, they trap Keap1, allowing Nrf2 to enter the nucleus and activate protective genes. However, SHKBP1 inhibits this sequestration. By limiting SHKBP1 p62 oligomerization, the protein keeps Keap1 available in the cytoplasm. Therefore, Keap1 continues to target Nrf2 for degradation, effectively tuning the cell's antioxidant response. This discovery provides a new perspective on how Cullin-3 adaptors modulate cellular health without relying on traditional enzymatic pathways.

Conclusion and Clinical Relevance

In addition to identifying a novel protein-protein interaction, these findings offer a deeper understanding of phase separation in biology. The study highlights how a non-ubiquitination-based mechanism can precisely control cellular stress responses. Notably, mutations or dysregulation in these pathways often contribute to oncogenesis and neurodegenerative diseases. Thus, targeting the SHKBP1-p62 axis could represent a future therapeutic strategy for managing oxidative stress-related disorders. Future research will likely focus on how this pathway interacts with other E3 ligases in diverse clinical settings.

Frequently Asked Questions

What is the primary function of SHKBP1 in p62 regulation?

SHKBP1 acts as a Cullin-3 adaptor that interacts with p62 to inhibit its oligomerization and assembly into phase-separated bodies, which regulates how the cell responds to stress.

How does SHKBP1 affect the Nrf2 antioxidant response?

By preventing the sequestration of Keap1 into p62 bodies, SHKBP1 ensures that Keap1 remains free to regulate Nrf2. This prevents the excessive activation of antioxidant genes under certain cellular conditions.

Is SHKBP1's effect on p62 dependent on ubiquitination?

No, the study highlights that SHKBP1 regulates p62 body formation through direct protein-protein interaction, which is independent of its potential roles in ubiquitination pathways.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

Luan L et al. Cullin-3 adaptor SHKBP1 inhibits SQSTM1/p62 oligomerization and Keap1 sequestration. J Cell Biol. 2026 Apr 06. doi: undefined. PMID: 41649860.

Baird L, Yamamoto M. The Molecular Mechanisms Governing the Keap1-Nrf2 Pathway. Mol Cell Biol. 2020;40(13):e00099-20.

Komatsu M, et al. The selective autophagy adapter p62/SQSTM1 activates Nrf2 through inactivation of Keap1. Nat Cell Biol. 2010;12(3):213-223.